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As with many complex genetic diseases, genome scans for prostate cancer have given conflicting results, often failing
to provide replication of previous findings. One factor contributing to the lack of consistency across studies is locus
heterogeneity, which can weaken or even eliminate evidence for linkage that is present only in a subset of families.
Currently, most analyses either fail to account for locus heterogeneity or attempt to account for it only by partitioning
data sets into smaller and smaller portions. In the present study, we model locus heterogeneity among affected sib
pairs with prostate cancer by including covariates in the linkage analysis that serve as surrogate measures of between-
family linkage differences. The model is a modification of the Olson conditional logistic model for affected relative
pairs. By including Gleason score, age at onset, male-to-male transmission, and/or number of affected first-degree
family members as covariates, we detected linkage near three locations that were previously identified by linkage
(1q24-25 [HPC1; LOD score 3.25, ], 1q42.2-43 [PCAP; LOD score 2.84, ], and 4q [LODPp .00012 Pp .0030
score 2.80, ]), near the androgen-receptor locus on Xq12-13 (AR; LOD score 3.06, ), andPp .00038 Pp .00053
at five new locations (LOD score 1 2.5). Without covariates, only a few weak-to-moderate linkage signals were
found, none of which replicate findings of previous genome scans. We conclude that covariate-based linkage analysis
greatly improves the likelihood that linked regions will be found by incorporation of information about heterogeneity
within the sample.
Introduction
Prostate cancer (CaP [MIM 176807]) is one of the most
common causes of cancer mortality among men in the
United States and accounts for ∼31,900 deaths annually
(Greenlee et al. 2000). Substantial differences in the
prevalence of CaP are observed among populations,with
African Americans having the highest prevalence of the
disease and with Asian populations having the lowest
prevalence (Parkin et al. 1993; Whittemore 1994). In-
dividuals either with several affected first-degree relatives
or with an affected brother who had an early age at
onset have a higher risk of development of CaP (Keetch
et al. 1995), suggesting that genetic factors play a role
in the development and progression of CaP. Studies of
the familial clustering of CaP also indicate a heritable
component of the disease, although there have been con-
flicting reports about the mode of inheritance. Some
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studies suggest an autosomal dominant mode of inher-
itance for early-onset disease (Carter et al. 1992; Gro¨n-
berg et al. 1997), whereas others suggest a recessive or
X-linked mode of inheritance (Monroe et al. 1995).
Numerous studies have indicated evidence for linkage
to regions that may contain a disease-susceptibility locus
for CaP. The first region, reported by Smith et al. (1996),
was on chromosome 1q24-25 (HPC1 [MIM 601518]).
Subsequent reports presented conflicting results in this
region. Some studies showed little or no support for a
locus in this region (McIndoe et al. 1997; Berthon et
al. 1998; Eeles et al. 1998; Berry et al. 2000a; Goode
et al. 2000), whereas others showed moderate support,
usually in subsets of the data restricted to families with
early age at onset (Hsieh et al. 1997; Gro¨nberg et al.
1999), families meeting the criteria for hereditary CaP
(Cooney et al. 1997), or families with male-to-male dis-
ease transmission, early age at onset, and a large number
of affected individuals (Xu and International Consor-
tium for Prostate Cancer Genetics 2000). A second locus
on chromosome 1, located at 1q42.2-43 (PCAP [MIM
602759]), was reported by Berthon et al. (1998). How-
ever, additional studies have failed to support the evi-
dence for linkage in this region (Gibbs et al. 1999a;
Whittemore et al. 1999; Berry et al. 2000a), although
the genome scan by Smith et al. (1996) had earlier re-
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ported a small-to-moderate signal in this region. A third
locus on chromosome 1, located at 1p36 (CAPB [MIM
603688]), was implicated in families that also have a
history of brain cancer (Gibbs et al. 1999b); however,
one other study showed negative LOD scores in this
region in 13 families with prostate and brain cancer
(Berry et al. 2000a).
Additional loci, on chromosomes other than chro-
mosome 1, also have been implicated in CaP and recently
were reviewed by Ostrander and Stanford (2000). In
brief, Xu et al. (1998) reported a locus, on the X chro-
mosome (HPCX [MIM 300147]), that had supportive
evidence of linkage in another study (Lange et al. 1999).
Berry et al. (2000b) identified evidence for linkage to a
locus on chromosome 20, among pedigreeswith nomale-
to-male transmission, a high average age at diagnosis
(66 years), and a relatively small number of affected
individuals (fewer than five affected). These families are
the least likely to have linkage to the regions that were
identified previously. More recently, the HPC2/ELAC2
gene on chromosome 17p was found to be associated
with an increased risk of CaP (Rebbeck et al. 2000; Tav-
tigian et al. 2000). Finally, two recent genome scans have
identified suggestive evidence for linkage on chromo-
somes 2, 12, 15, and 16 (Suarez et al. 2000) and on
chromosomes 1, 8, 10, 12, 14, and 16 (Gibbs et al. 2000).
The strongest evidence for linkage was found on chro-
mosome 16, in the affected-sib-pair (ASP) study by
Suarez et al. (2000), and on chromosomes 8 and 10,
under a recessive model, in the Gibbs et al. (2000) study.
The mixed results observed both within and between
studies is an indication of the complex nature of CaP.
CaP is likely to be a genetically heterogeneous disorder,
with several genetic and environmental factors contrib-
uting to the development of disease. Two additional
factors are likely to contribute to the lack of consistency
across studies. First, theremay be population differences
both within and between studies; for example, in the
original report for HPC1, two African American ped-
igrees contributed substantially to the total LOD score
suggesting linkage in the region, whereas many subse-
quent studies included a large proportion of white fam-
ilies. Second, differences in the ascertainment criteria
used to identify pedigrees can lead to different genes
segregating in the study population (McCarthy et al.
1998; Goddard 1999). Many of the studies listed above
selected large pedigrees with a large number of affected
individuals, whereas others included only nuclear fam-
ilies with at least two affected individuals.
Previous analyses have used several methods to deal
with heterogeneity, including alternative models in par-
ametric linkage analysis; model-free methods, such as the
nonparametric linkage (NPL) score; and stratification of
the sample on one or more covariates. An alternative
method that may provide additional power to detect link-
age is the model-free conditional logistic model for af-
fected-relative-pair (ARP) linkage analysis (Olson 1999),
an extension and reparameterization, in terms of log risk
ratio, of the Greenwood and Bull (1999) multinomial
covariate model for ASPs. Greenwood and Bull estab-
lished, using simulations, that inclusion of family-specific
covariates increases the power to detect linkage, provided
that the covariate reflects underlying locus heterogeneity.
They also found that inclusion of covariates does not
substantially impact the accuracy of asymptotic approx-
imations to the distribution of the appropriate likelihood-
ratio statistic, regardless of whether constraints on the
mode of inheritance are applied that reduce the number
of parameters in the model.
These methods are model free in the sense that model
parameters at the trait locus do not need to be specified.
Discrete or quantitative covariates included in themodel
increase power to detect linkage when the covariate
measures differences, between families, that are impor-
tant to locus heterogeneity. The method incorporates
locus heterogeneity due to the covariate, by allowing
the genetic relative risk to depend on the covariate, so
that, in effect, the allele sharing at the marker locus
differs for different values of the covariate. The original
model proposed by Olson (1999) requires two addi-
tional parameters for each covariate and therefore may
not provide optimal power. In the present study, we
instead use a modification that requires only one ad-
ditional parameter per covariate.
We apply this modification of the Olson (1999) con-
ditional logistic model to a genome scan of sibships with
CaP. We test four covariates: Gleason score, age at on-
set, male-to-male transmission, and number of first-de-
gree relatives with CaP. In contrast to the original anal-
ysis of these data by Suarez et al. (2000), we find strong
confirmatory evidence of linkage in four genomic lo-
cations, as well as substantial evidence for linkage in
several new locations.
Subjects and Methods
Subjects
The recruitment of study subjects has been described
elsewhere (Suarez et al. 2000; Witte et al. 2000). For
this analysis, a total of 564 men from 254 families with
both CaP and measured Gleason scores were available.
This sample included 189 families with two affected
brothers, 41 families with three affected brothers, 2 fam-
ilies with four affected brothers, and 1 family with two
pairs of affected brothers who were cousins (for a total
of 326 ASPs). We considered four covariates: (1) the sum
of the sib-pair Gleason scores, (2) age at onset (measured
as family mean age at diagnosis), (3) an indicator for
male-to-male transmission in the nuclear family, and (4)
Goddard et al.: Linkage Analysis with Covariates in CaP 1199
the number of affected first-degree relatives in the nu-
clear family. Gleason score is a measure of tumor ag-
gressiveness and has been analyzed previously, as an out-
come variable, by use of these data (Witte et al. 2000).
Family mean age at diagnosis was used in place of the
sum of the sib-pair age at onset, because of the large
number of missing values for the latter. Overall, 4% of
the ASPs had missing values for male-to-male transmis-
sion, and 11% of ASPs had missing values for the family
mean age at diagnosis. Missing values for covariates
other than Gleason score were given the mean value for
that covariate.
Genotyping
Genotyping was performed at the Center for Medical
Genetics, Marshfield Medical Research Foundation,
with DNA from each subject’s peripheral blood, ex-
tracted by standard methods. The samples were typed
through use of Marshfield Screening Set 9 (Yuan et al.
1997), which includes 364 autosomal simple-tandem-
repeat polymorphisms, with ∼9-cM spacing between
markers across the genome and an average heterozy-
gosity of 77% (Broman et al. 1998). We confirmed the
sib-pair relationship in all sibships, through use of all
markers in the screening set, with the programRELTEST
from the Statistical Analysis for Genetic Epidemiology
(S.A.G.E.) software package, release 4.0 beta. Pairs that
were not full siblings or that were MZ twins were ex-
cluded from the analysis, as in previous analyses of these
data (Suarez et al. 2000; Witte et al. 2000).
Statistical Analysis
To detect linkage in our ASPs, we performed a model-
free likelihood analysis that allowed incorporation of co-
variates. Olson (1999) showed that the original Risch
(1990) ASP LOD score can be reparameterized in terms
of the natural logarithms of relationship relative risks, by
putting and , where l1 (l2) isl p exp (b ) l p exp (b )1 1 2 2
the relative risk for a pair of relatives that shares exactly
1 (2) alleles identical by descent (IBD) and where b1 (b2)
is the natural logarithm of l1 (l2). In this analysis, mul-
tipoint IBD-sharing estimates for autosomal loci were ob-
tained with the GENIBD program from the S.A.G.E.
package, release 4.0 beta, and those for the X chromo-
some were obtained with MAPMAKER/SIBS (Kruglyak
and Lander 1995). Addition of covariates to this model
requires two additional parameters for each covariate.
Instead, we constrained the relative risks so that l p2
, reducing, from two to one, both the3.634l  2.6341
number of parameters in the basic model and the number
of additional parameters needed for each added covariate.
This particular constraint was chosen on the basis ofwork
by Whittemore and Tu (1998), who showed that a min-
max one-parameter ASP LOD score preserved type I error
but had more power for most genetic models than did
the usual two-parameter LOD score. Our constraint is
simply a reparameterization of the Whittemore-Tu min-
max constraint and assumes a genetic model approxi-
mately halfway between a recessive and a dominantmode
of inheritance. We then incorporated covariates into our
analysis by putting where xi,
Kl p exp (b  g x ),1 1 i i
, are the covariates included in the model andip 1,… ,K
where gi are the corresponding parameters. The same
model may be used on X-linked markers after the correct
prior and conditional allele-sharing probabilities for X-
linked loci and brother-brother pairs are obtained, where
the interpretation of l1 is specific to that pair type.
In this analysis, inclusion of a covariate allows for link-
age heterogeneity due to the covariate; for example, a
binary covariate indicating population membership al-
lows for population heterogeneity in linkage to a partic-
ular location, and including such a covariate is equivalent
to analyzing each subpopulation separately and summing
the LOD scores. Continuous covariates have a similar
interpretation in that they allow for linkage heterogeneity
due to the covariate. Using the parameter estimates, one
can then calculate sibling relative risks at particular values
of the covariate: , subject to1 1 1l (x)p  l (x) l (x)s 1 24 2 4
the minmax constraint described above.
In our analyses, we assumed that genetic constraints
(Holmans 1993) hold at the sample mean covariate
value, but not necessarily at other covariate values (see
Greenwood and Bull 1999); each covariate was stan-
dardized to have mean 0 and variance 1. By centering
the covariate around 0, we avoid the need to further
constrain g to be consistent with a genetic model at the
mean covariate value (Olson 1999). In addition, the sign
of g indicates the direction of covariate effect on linkage
evidence; for example, if linkage is present in families
with early age at onset but absent in families with late
age at onset, inclusion of x (as mean age at onset [cen-
tered]) as a covariate will substantially increase the LOD
score, and the estimate of g will be negative, generating
the highest values of ls(x) for the lowest values of x. In
addition to centering each covariate, we also standard-
ized by dividing by the estimated SD. The sole purpose
was to reduce the number of possible computation-
al problems encountered by the maximization algo-
rithmMAXFUN from the S.A.G.E. package, release 2.2;
115,000 separate maximizations were performed in this
analysis.
Critical values for the corresponding likelihood-ratio
statistics (LRS; i.e., ) can be obtained4.605# LOD score
easily, by use of the methods of Self and Liang (1987).
The distribution of the LRS for the basic one-parameter
model is a 50:50 mixture of a point mass at 0 and a x2
distribution with 1 df. Addition of K covariates gives an
LRS with a distribution that is a 50:50 mixture of a x2
with K df and a x2 with df. The difference in LRSK 1
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between nested models that differ by J covariates has a
x2 distribution with J df. One can therefore test both the
significance of the contribution of a covariate and the
overall evidence for linkage.
Clearly, addition of covariates increases the LOD cut-
point needed in order to allow us to declare that there
is significant linkage. As a result, we encourage both a
priori selection of candidate covariates to be included in
routine linkage analysis and careful differentiation be-
tween planned and exploratory analyses. We chose co-
variates that we believed had a high probability of mea-
suring some aspect of locus heterogeneity and analyzed
each covariate individually. In regions where more than
one covariate contributed significantly to linkage evi-
dence ( ), we obtained parsimonious final models,P ! .05
using multiple-regression methods.
Results
Plots of LOD score versus map distance (in cM) are
shown in figure 1, for five models: the one-parameter
model, without covariates, and four models, each with
one covariate (Gleason score, mean age at onset, male-
to-male transmission indicator, or number of affected
relatives). The one-parameter model, represented by the
black line, is always the smallest of the five LOD scores
and can be viewed as a “baseline” in the context of the
analysis of covariate effects on linkage. Five regions have
baseline LOD scores 11; these regions are summarized
in table 1, along with the corresponding two-parameter
LOD score and the NPL score reported, by Suarez et al.
(2000), for the same data set. The largest one-parameter
LOD score is on chromosome 2q (LOD score 2.48). We
detected the same regions reported by Suarez et al.
(2000), with some differences in relative magnitude of
the signal, which, presumably, reflect differences in
method power and the fact that Suarez et al. included
more markers in these regions and used a larger sample
size by including ASPs with no reported Gleason score.
Comparison of the one- and two-parameter LOD scores
shows the dependence of the results on the constraints
that were chosen for the one-parameter model. These
results indicate that, at the cost of an additional param-
eter, the two-parameter model adds little additional ev-
idence for linkage, a finding that is consistent with the
results of Whittemore and Tu (1998) that also suggest
that the one-parameter model is usually more powerful.
Similar increases in the LOD score were found by max-
imizing over the mode-of-inheritance parameter (two-
parameter model) for models that included the covar-
iates (data not shown).
Covariate effects significant at the .01 level are de-
tailed in table 2, as are regions for which the total LOD
score (including the covariate) is 12.0. We included con-
siderable detail in this table so that various features of
the new models can be observed more easily. Because
all covariates were standardized prior to inclusion, co-
variate-parameter estimates (g) are interpreted as unit
changes in loge offspring relative risk l1 of the stan-
dardized covariate. The means and SDs of the original
covariates are given in footnote “b” of table 2.
Some of the most interesting results were on chromo-
some 1. In the region that purports to contain HPC1,
a large peak (LOD score 3.25) was found only when
Gleason score was included as a covariate. The highest
point of our peak was located ∼30 cM centromeric to
the most significant marker described by Smith et al.
(1996). The LOD score without covariates is only 0.03,
and the effect of Gleason score on linkage at this lo-
cation is highly significant ( ). This signal isPp .00012
the largest Gleason-score effect in our genome scan. The
sign of the covariate parameter is positive, indicating
that ASPs with high Gleason scores show the strongest
evidence for linkage. Sibling relative risks for various
Gleason scores are given in table 3, to illustrate the
dependence of relative risk on Gleason score; ASPs with
total Gleason scores in the upper 2.5% of the sample
distribution have sibling relative risks 12.52.
A second peak on chromosome 1 is in the region of
the PCAP signal reported by Berthon et al. (1998).
Again, the model without covariates shows little evi-
dence for linkage (LOD score 0.32), whereas the model
that includes male-to-male transmission gives a LOD
score of 1.90 ( for the covariate effect). Fam-Pp .007
ilies that have male-to-male transmission show the most
evidence in favor of linkage. In addition, Gleason score
and number of affected relatives both are significant at
the .05 level. As a result, we fit multiple conditional
logistic-regression models (table 4). The best-fitting,
most-parsimonious model includes both Gleason score
and male-to-male transmission (total LOD score 2.84,
). The interaction term has a negligible effect,Pp .003
indicating an excellent fit to a model in which these
covariates affect offspring relative risk l1 multiplica-
tively. The signs of the covariate parameters in the final
model indicate that ASPs with male-to-male transmis-
sion and low Gleason scores contain the most evidence
for linkage to the PCAP region on chromosome 1. The
number of affected relatives does not add linkage in-
formation once Gleason score and male-to-male trans-
mission are taken into account.
A second large signal due primarily to Gleason score
was found on chromosome X ( for covariatePp .0003
effect), ∼10 cM telomeric from the androgen-receptor
locus (AR [MIM 313700]), an important candidate locus
for CaP. CAG- and GGN-repeat polymorphisms in the
AR locus have been related to CaP in association studies
(e.g., see Giovannucci et al. 1997; Ingles et al. 1997;
Stanford et al. 1997; Hsing et al. 2000) but not in linkage
studies (Lange et al. 2000). For this signal, the LOD score
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Table 1
Baseline Linkage Results
CHROMOSOME
FLANKING
MARKER(S)
PEAK LOCATIONa
(cM)
LOD SCORE (P VALUE)
PEAK LOCATION
BY NPLa
(cM)
NPL SCOREb
(P VALUE)One-Parameter Two-Parameter
2q D2S434, D2S1363 220 2.48 (.0004) 2.79 (.0003) 224 2.78 (.0027)
12p D12S372 0 1.55 (.0038) 1.64 (.0050) 8 2.00 (.0228)
15p D15S165, ACTC 10 1.02 (.0151) 1.10 (.0190) 24 2.77 (.0028)
16p D16S748, D16S764 16 1.70 (.0026) 1.74 (.0039) 32 2.81 (.0025)
16q D16S2624, D16S516 88 1.07 (.0132) 1.13 (.0176) 99 3.15 (.0008)
a Distance is measured from the first marker on the chromosome.
b From Suarez et al. (2000). ASPs.Np 320
without the covariate was only 0.26, compared with the
LOD score including the covariate, which was 3.06, a
strongly significant value ( ). In contrast toPp .00058
what has been observed in the HPCX region (Xu et al.
1998; Lange et al. 1999), we did not observe an increase
in the evidence for linkage among families with trans-
mission that was consistent with an X-linked mode of
inheritance (i.e., families that did not have male-to-male
transmission). We could not examine the chromosome
X region previously reported by Xu et al. (1998) because
we did not have markers in this region near Xqter.
A third large signal, due entirely to Gleason score,
was found on chromosome 5 ( for covariatePp .00058
effect), in a location different from the location iden-
tified by Witte et al. (2000) when they used Gleason
score as a dependent variable in a Haseman-Elston re-
gression. Gleason score also increases the signal on
chromosomes 2 (two regions), 8, and 16. The largest
effect of age at onset was on chromosome 14, where
the linkage signal increased from 0.18 to 2.74. Chro-
mosomes 4, 6, 7, and 20 showed smaller age-at-onset
effects, which were significant at the .01 level. The larg-
est effect of male-to-male transmission was found on
chromosome 21, where the LOD score increased from
0.32 to 3.12. Chromosomes 1–5 also showed effects
from this covariate, which were significant at the .01
level.
The largest effects of the number of affected relatives
were on chromosomes 3 (increase in LOD score from
0.00 to 4.66), 4 (from .03 to 2.76), and 8 (from 0.00
to 2.56), with another smaller but significant effect on
chromosome 8. The signal on chromosome 4 is in the
region of the second-largest signal reported by Smith et
al. (1996). In this region, male-to-male transmission
also shows an individual effect, which is significant at
the .05 level, but it does not add linkage evidence to
the model that includes the number of affected relatives.
None of the other large covariate effects corresponds
to a region for which previous strong linkage evidence
has been reported.
The signal on chromosome 3 appears unusually nar-
row and may be overestimated or improperly maxi-
mized. However, we were unable to discover any dif-
ficulties with the maximization procedures at this
location. An additional indication of possible overes-
timation is revealed by the fact that the linkage-param-
eter estimate (b) is 0 but the covariate-parameter esti-
mate (g) is large in absolute value; in other words, the
offspring relative risk for much of the covariate distri-
bution is considerably less than 1. In our analyses, we
constrained only the mean covariate value to be con-
sistent with genetic-triangle constraints, because it re-
mains unclear what, if any, genetic constraints should
be imposed when a covariate cannot be considered to
differentiate subpopulations in which the genetic con-
straints should separately conform (e.g., different mat-
ing populations).
Nonetheless, one generally expects true relative risk
values to be1; on the other hand, if linked and unlinked
subsets are indeed present, estimated relative risks in the
unlinked subset will be !1, with probability 1/2, by
chance alone; in fact, we believe that chance evidence
against linkage in unlinked (and unidentified) subsets is
one of the primary reasons that linkage is often not de-
tected in the first place. Therefore, we hesitate to discount
signals that yield some implausible relative-risk values,
while recognizing that, in some regions, the size of the
detected covariate effect may be distorted and that the
LOD score may be inflated.
Discussion
A reanalysis of the genome-scan data first reported by
Suarez et al. (2000) provides confirmatory evidence of
linkage in two regions, first reported by Smith et al.
(1996), on chromosome 1 (i.e., HPC1) and on chro-
mosome 4, and in one region, highlighted by Berthon
et al. (1998), on chromosome 1 (i.e., PCAP), which also
had a moderate-sized signal reported by Smith et al.
(1996). Our peaks on chromosome 4 and 1q42.2-43
appear to be within 10–20 cM of their previously re-
ported locations. We estimate that our HPC1 peak may
be 30 cM centromeric to its previously reported location.
In addition, we observed a strong new signal, on chro-
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Table 2
Significant Covariates
Chromosome and Flanking Marker(s)
(Position [in cM]) Z1
a b Covariateb Z2
c b g Z Z2 1 P
1:
D1S534, D1S1653 (156) .03 .019 Gleason 3.25 .110 .311 3.22 .0001
D1S549, D1S3462 (240) .32 .065 Male 1.90 .106 .236 1.58 .0070
2:
D2S1360 (35) .00 .000 Gleason 1.52 .000 .115 1.52 .0082
D2S1384, D2S1649 (204) 1.06 .126 Male 2.79 .171 .266 1.73 .0048
D2S434, D2S1363 (220) 2.48 .205 Gleason 3.29 .216 .140 .81 .053
D2S434, D2S1363 (218) 2.48 .205 Male 3.40 .244 .216 .92 .040
3:
D3S1768 (61) .00 .000 Male 1.51 .000 .162 1.51 .0084
D3S1262, D3S2398 (202) .00 .000 No. affected 4.66 .000 .236 4.66 !.0001
4:
D4S403, D4S2639 (16) .00 .000 Age at onset 1.80 .012 .168 1.80 .0040
D4S2623, D4S2394 (110) .06 .030 No. affected 2.80 .096 .237 2.74 .0038
D4S2394, D4S1644 (120) .00 .003 Male 1.76 .019 .116 1.76 .0044
5:
D5S1457, D5S2500 (56) .00 .000 Gleason 2.57 .023 .207 2.57 .0006
6:
GATA184A08, D6S2436 (140) .00 .000 Age at onset 1.53 .033 .175 1.53 .0079
7:
D7S1802, D7S1808 (32) .00 .000 Age at onset 1.55 .013 .081 1.55 .0075
D7S1802, D7S1808 (26) .00 .000 Male 1.75 .012 .112 1.75 .0045
D7S3046, D7S2204 (74) .00 .000 Age at onset 1.68 .000 .139 1.68 .0054
8:
D8S1106, D8S1145 (28) .04 .016 No. affected 1.92 .022 .139 1.88 .0033
D8S1119 (101) .39 .066 Gleason 1.88 .096 .123 1.49 .0029
GAAT1A4, D8S1132 (114) .00 .000 No. affected 2.56 .058 .253 2.56 .0006
12:
D12S372 (0) 1.55 .200 Gleason 2.32 .179 .129 .77 .0600
14:
D14S1434, D14S1426 (94) .03 .051 Age at onset 2.75 .114 .310 2.72 .0040
15:
D15S165, ACTC (8) 1.02 .114 Male 2.42 .043 .124 1.40 .0110
16:
D16S764 (19) 1.59 .152 No. affected 2.68 .162 .096 1.09 .0250
D16S2621 (120) .13 .040 Gleason 1.65 .064 .137 1.52 .0082
20:
D20S171 (94) .00 .000 Age at onset 1.81 .000 .127 1.81 .0039
21:
D21S2055 (37) .32 .060 Male 3.12 .083 .141 2.80 .0003
X:
DXS6789, DXS6797 (101) .26 .153 Gleason 3.06 .171 .533 2.80 .0003
a LOD score for one-parameter model.
b Mean (SD) of covariates—total Gleason score, 11.30 (2.13); age at onset, 63.1 (8.30); Male-to-male transmission,
0.166 (.36); Number of affected relatives, 2.74 (.83).
c LOD score for model including covariate.
mosome Xq12-13, that appears to be within 10–15 cM
of the AR locus, a major candidate locus for CaP. We
were able to detect these signals by including in the link-
age analysis those covariates that account for some of
the genetic heterogeneity presumed to exist in this com-
plex disease. Linkage analysis without covariates failed
to detect the signals in these regions. We believe that
analyses that include additional phenotypic information
will greatly improve the ability of genome scans to detect
genetic loci for complex diseases.
Other covariate-based linkage methods have been pro-
posed in addition to those of Olson (1999) and Green-
wood and Bull (1999). Schaid et al. (2001 [in this issue]),
in the context of model-based linkage analysis, specify
the heterogeneity parameter as a function of covariates
and apply the method to CaP. Gauderman and Siegmund
(2000) have proposed a method in which gene-by-envi-
ronment interaction is included in ASP linkage analysis.
Although linkage analysis with covariates is not yet com-
monplace, it is similar in spirit to the common practice
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Table 4
Multiple-Regression Analysis of Chromosome 1q42.2-43
Model LOD Score
Overall
P value
LOD-Score
Differencea P value
One-parameter .32 .1124 … …
Gleason (G) 1.53 .0187 1.21 .0182
Age at onset .33 .3427 .01 .930
Male-to-
male trans-
mission (M)
1.90 .0078 1.58 .007
No. affected
(N)
1.42 .0243 1.10 .0244
GM 2.84 .00296 .94 .0376
GMN 2.87 .00723 .03 .710
GMG*M 2.86 .00738 .02 .762
a To nearest model with one less parameter.
Table 3
Relative-Risk Estimates, at Chromosome 1q24-25
GLEASON SCOREa (x)
RELATIVE RISK
Offspring [l1(x)] Sibling [ls(x)]
2.0 .60 .44
1.0 .82 .74
0 1.12 1.16
1.0 1.52 1.74
2.0 2.08 2.52
a Sib-pair summed Gleason-score value, in SD.
of subgroup analysis, in that subgroup analysis also aims
to account for locus heterogeneity. One advantage of the
conditional logistic model is that it provides a more gen-
eral way in which covariate information can be easily
included in the linkage analysis. The form of the mod-
el allows for multiple covariates—including quadratic
terms and interactions—to be modeled, without the need
to subdivide a sample into smaller and smaller portions.
For continuous covariates, it is not necessary to choose
a cutpoint on the basis of which the data are to be sub-
grouped. One possible disadvantage is that the model
assumes multiplicativity in offspring relative risk; how-
ever, this restriction can be partly overcome, if necessary,
to provide a better fit, by the inclusion of higher-order
terms or by the transformation of covariates.
Addition of covariates increases the LOD-score cut-
point needed in order to allow us to declare significant
linkage. In addition, indiscriminate use of covariate
analyses can result in greatly increased experiment-wise
type I error, because of multiple testing. As a result, we
encourage both a priori selection of candidate covariates
to be included in routine linkage analysis and careful
distinction between prespecified and exploratory anal-
yses. More-rigorous rules for multiple testing await fur-
ther research.
The influence of missing data on the results of an
analysis is always a concern. Here, missing data for
covariates were replaced with the mean covariate value.
The age-at-onset covariate had the largest proportion
of missing data, with 11% of the ASPs having missing
values. Removing from the analysis the ASPs having
missing values for this covariate slightly reduced the
LOD score; however, it is unclear whether this is an
indication of a biased result due to use of the mean
covariate value or of additional information that is
gained by inclusion of the ASPs having missing values.
Witte et al. (2000) analyzed these data by using Glea-
son score as a dependent variable in a (new) Haseman-
Elston regression (Elston et al 2000); there was little, if
any, overlap between the signals reported in the present
article and the signals reported byWitte et al. We believe
that the two analyses detect different types of infor-
mation relevant to linkage. Using Gleason score as a
dependent variable in a sample of ASPs is likely to pro-
vide the most power to detect genes that modify tumor
aggressiveness in patients with CaP but that do not con-
fer susceptibility to CaP itself—that is, genes that con-
tribute to within-family variability in Gleason score; on
the other hand, inclusion of Gleason score as a covariate
in an ASP linkage analysis is likely to have the most
power to detect genes that confer susceptibility solely
to subtypes of CaP that are characterized by aggressive
tumors—that is, genes that contribute to between-fam-
ily variability in Gleason score.
However, we note that, for individual-specific covar-
iates, covariate information relevant to locus hetero-
geneity may be present in the sib-pair covariate sum,
the sib-pair covariate difference, or both. One can in-
clude the sib-pair difference as an additional covariate
if one believes that between-family differences inwithin-
family variability contribute to locus heterogeneity. For
the five largest Gleason-score signals, we added the sib-
pair difference to the model but found no significant
increase in LOD score. We are currently using simula-
tions to explore these and other models of covariate
action, and we plan to report the findings in a future
publication. The one-parameter conditional logistic
model for ARPs is expected to be available in the next
release of S.A.G.E.; a beta version of the program is
currently available from the Human Genetic Analysis
Resource Web site.
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